• Accueil
• agenda 2025
• 2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA - Lexology

2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA - Lexology

4.7 (644) · € 30.00 · En Stock

ANVISA’s new Regulatory Agenda 2024-2025 (RA 24/25) was approved and published on the Official Gazette on December 18th. The Joint Ordinance No. 1…

2023 - 2025 Action Plan for the Brazilian Intellectual Property

6th Neuroimmunology Drug Development Summit

Abstract Submissions - WORLDSymposium

Celltrion's Vegzelma Becomes Fourth US-Approved Bevacizumab

Advertising law, year in review

In review: the life sciences regulatory regime in Brazil - Lexology

Abstracts – Ever Congress

Snapshot: procedure for design registration in Brazil - Lexology

Anvisa publishes new Regulatory Agenda for 2024-2025 — Food

February 7, 2023: FDA Issues Draft Guidance for Use of Real-World